Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,450 | 34,931 | 43,200 | 39,520 | 46,880 |
| Receivables | 598 | 867 | 1,950 | 7,990 | 7,710 |
| Inventories | N/A | N/A | 0 | 4,080 | 3,450 |
| Other current assets | 0 | 0 | 500 | 1,710 | 2,090 |
| TOTAL | $42,394 | $36,217 | $45,650 | $53,300 | $60,130 |
| Non-Current Assets | |||||
| PPE Net | 256 | 797 | 1,350 | 2,140 | 2,510 |
| Intangibles | 8,073 | 9,039 | 0 | 0 | 0 |
| Other Non-Current Assets | 775 | 1,382 | 12,190 | 12,210 | 12,710 |
| TOTAL | $9,104 | $11,218 | $13,540 | $14,350 | $15,220 |
| Total Assets | $51,498 | $47,435 | $59,190 | $67,660 | $75,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 0 | 50 |
| Accounts payable and accrued liabilities | 4,172 | 5,799 | 7,240 | 6,670 | 8,060 |
| Accrued Expenses | N/A | N/A | 0 | 3,760 | 3,170 |
| Other current liabilities | 2,009 | 1,505 | 0 | 5,260 | 6,330 |
| TOTAL | $6,425 | $7,574 | $7,240 | $15,700 | $17,880 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 244 | 270 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 22,971 | 24,568 | 34,890 | 23,990 | 22,780 |
| TOTAL | $23,458 | $25,377 | $34,890 | $58,650 | $62,020 |
| Total Liabilities | $29,883 | $32,951 | $42,130 | $74,360 | $79,910 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 7 | 5 | 3 | N/A |
| Common Shares | 204,596 | 150,544 | 134,100 | 122,790 | 101,880 |
| Retained earnings | -271,621 | -222,322 | -203,920 | -213,080 | -188,960 |
| Other shareholders' equity | 88,640 | 86,262 | 86,880 | 83,600 | 82,540 |
| TOTAL | $21,615 | $14,484 | $17,060 | $-6,690 | $-4,540 |
| Total Liabilities And Equity | $51,498 | $47,435 | $59,190 | $67,670 | $75,370 |